The first intramammary antibiotic developed in Latin America containing Cephalexin, Neomycin Sulfate, and Prednisolone, indicated for all bacterial infections.
CEFTOCIDIN is indicated for all bacterial infections involving the mammary gland that manifest as clinical mastitis. It provides an antimicrobial effect to eliminate the infection while controlling inflammation in the gland, ensuring reduced scarring and preventing a decrease in milk production.
Start treatment at the first signs of mastitis. Before application, the affected teat must be emptied as much as possible, and proper hygiene must be carried out. CEFTOCIDIN is a STERILE PRODUCT sterilized by irradiation. Open only at the time of administration. After that, simply apply. Massage the teat from its base to ensure proper product distribution. It is recommended to administer 1 dose every 12 hours, totaling 6 applications, or as directed by a veterinarian.
Sold in a styrofoam box for thermal insulation, containing 20 syringes of 5 mL each.
Composition (per 100 mL):
| Monohydrate Cephalexin | 2 g |
| Neomycin Sulfate | 2 g |
| Prednisolone | 0.1 g |
It is recommended to start treatment as soon as the first signs of mastitis appear. Before administering CEFTOCIDIN Acute Mastitis, the affected teat should be emptied as much as possible, and proper hygiene must be performed. As it is a STERILE PRODUCT, only at the time of administration should the injector be removed from its wrapper, the cannula inserted into the teat, and the full contents discharged. The teat should be massaged from its base, facilitating product distribution. It is recommended to administer 1 dose every 12 hours, totaling 6 applications, or as directed by a veterinarian.